Kurt W Evans

7PUBLICATIONS
107CO-AUTHORS
Molecular targetsTumour immunologyHaematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 29, 2025
Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations.

Kaushik Varadarajan, Christian X Cruz Pico, Kurt W Evans

|Nov 25, 2024
Antitumor Activity and Biomarker Analysis for TROP2 Antibody-Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models.

Funda Meric-Bernstam, Erkan Yuca, Kurt W Evans

|Nov 08, 2024
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer.

Timothy P DiPeri, Kurt W Evans, Stephen Scott

|Jul 31, 2024
A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis.

Brian S White, Xing Yi Woo, Soner Koc

|Apr 19, 2024
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations.

Funda Meric-Bernstam, Michael W Lloyd, Soner Koc

|Feb 15, 2024
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts.

Timothy P DiPeri, Kurt W Evans, Bailiang Wang

Pageof 2

Frequent Collaborators

7 joint publications

Funda Meric-Bernstam

6 joint publications

Maria Gabriela Raso

5 joint publications

Ming Zhao

5 joint publications

Yasmeen Rizvi